-
Observational Study
Influence of statin treatment in a cohort of patients admitted for COVID-19.
- Juan R Rey, José Luis Merino Llorens, Ángel Manuel Iniesta Manjavacas, Sandra Ofelia Rosillo Rodríguez, Sergio Castrejón-Castrejón, Emilio Arbas-Redondo, Isabel Dolores Poveda-Pinedo, Daniel Tebar-Márquez, Andrea Severo-Sánchez, Borja Rivero-Santana, Víctor Juárez-Olmos, Marcel Martínez-Cossiani, Antonio Buño-Soto, Luis Gonzalez-Valle, Alicia Herrero-Ambrosio, Esteban López-de-Sá, and Juan Caro-Codón.
- Servicio de Cardiología, Hospital Universitario La Paz, Madrid, España. Electronic address: juanr.rey@salud.madrid.org.
- Med Clin (Barc). 2022 Jun 24; 158 (12): 586595586-595.
Aims And ObjectivesStatins have been proposed as potentially useful agents for modulating the host response in COVID-19. However, solid evidence-based recommendations are still lacking. Our aim was to study the association between statin use and clinical outcomes in a large cohort of hospitalized patients with SARS-CoV-2 infection, as well as the specific consequences of chronic treatment withdrawal during hospital admission.Material And MethodsRetrospective observational study including 2191 hospitalized patients with confirmed SARS-CoV-2 infection.ResultsMean age was 68.0±17.8 years and 597 (27.3%) patients died during follow-up. A total of 827 patients (37.7% of the whole sample), received chronic treatment with statins. Even though they underwent more frequent admissions in critical care units, chronic treatment with statins was not independently associated with all-cause mortality [HR 0.95 (0.72-1.25)]. During the whole hospital admission, 371 patients (16.9%) received at least one dose of statin. Although these patients had a significantly worse clinical profile, both treatment with statins during admission [HR 1.03 (0.78-1.35)] and withdrawal of chronic statin treatment [HR 1.01 (0.78-1.30)] showed a neutral effect in mortality. However, patients treated with statins presented more frequently hepatic cytolysis, rhabdomyolysis and thrombotic/hemorrhagic events.ConclusionsIn this large cohort of hospitalized COVID-19 patients, statins were not independently associated with all-cause mortality during follow-up. Clinically relevant statin-associated adverse effects should be carefully monitored during hospital admission.Copyright © 2021 Elsevier España, S.L.U. All rights reserved.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.